Laxai Pharma - 34 Year Stock Price History | LAXAF
Historical daily share price chart and data for Laxai Pharma since 1989 adjusted for splits and dividends. The latest closing stock price for Laxai Pharma as of October 04, 2023 is 0.00.
- The all-time high Laxai Pharma stock closing price was 13.50 on November 08, 1993.
- The Laxai Pharma 52-week high stock price is 0.00, which is % above the current share price.
- The Laxai Pharma 52-week low stock price is 0.00, which is % below the current share price.
- The average Laxai Pharma stock price for the last 52 weeks is 0.00.
| Laxai Pharma Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.00% |
| 2022 | 0.0021 | 0.0050 | 0.0050 | 0.0001 | 0.0001 | -98.00% |
| 2021 | 0.0110 | 0.0055 | 0.0249 | 0.0032 | 0.0050 | -9.09% |
| 2020 | 0.0118 | 0.0195 | 0.0500 | 0.0030 | 0.0055 | -71.65% |
| 2019 | 0.0241 | 0.0070 | 0.1388 | 0.0045 | 0.0194 | 1663.64% |
| 2018 | 0.0011 | 0.0008 | 0.0039 | 0.0006 | 0.0011 | -35.29% |
| 2017 | 0.0012 | 0.0007 | 0.0020 | 0.0004 | 0.0017 | 183.33% |
| 2016 | 0.0012 | 0.0012 | 0.0080 | 0.0005 | 0.0006 | -50.00% |
| 2015 | 0.0016 | 0.0027 | 0.0027 | 0.0011 | 0.0012 | -55.56% |
| 2014 | 0.0023 | 0.0045 | 0.0045 | 0.0012 | 0.0027 | 8.00% |
| 2013 | 0.0031 | 0.0021 | 0.0074 | 0.0011 | 0.0025 | 19.05% |
| 2012 | 0.0058 | 0.0010 | 0.0120 | 0.0001 | 0.0021 | 110.00% |
| 2011 | 0.0094 | 0.0098 | 0.0500 | 0.0010 | 0.0010 | -88.89% |
| 2010 | 0.0670 | 0.0400 | 0.2500 | 0.0056 | 0.0090 | -85.00% |
| 2009 | 0.0485 | 0.0400 | 0.0700 | 0.0110 | 0.0600 | 100.00% |
| 2008 | 0.3731 | 0.9000 | 0.9412 | 0.0300 | 0.0300 | -96.70% |
| 2007 | 1.1547 | 1.3500 | 1.7000 | 0.8000 | 0.9100 | -36.36% |
| 2006 | 0.8291 | 0.6500 | 2.6400 | 0.4700 | 1.4300 | 90.67% |
| 2005 | 0.6859 | 0.7200 | 1.0990 | 0.5000 | 0.7500 | 17.19% |
| 2004 | 0.9649 | 1.1800 | 1.4900 | 0.6000 | 0.6400 | -43.86% |
| 2003 | 0.8409 | 0.4400 | 1.7000 | 0.2500 | 1.1400 | 159.09% |
| 2002 | 0.4348 | 0.5300 | 0.6600 | 0.2000 | 0.4400 | -21.43% |
| 2001 | 0.7511 | 0.8750 | 1.0312 | 0.4800 | 0.5600 | -28.32% |
| 2000 | 1.8700 | 1.1250 | 3.8438 | 0.7812 | 0.7812 | -16.67% |
| 1999 | 1.0104 | 0.8750 | 1.5000 | 0.7500 | 0.9375 | 7.14% |
| 1998 | 1.2984 | 1.5000 | 2.0000 | 0.8438 | 0.8750 | -56.25% |
| 1997 | 1.9484 | 2.5000 | 3.0000 | 1.5000 | 2.0000 | -20.00% |
| 1996 | 3.7929 | 3.8752 | 5.5000 | 2.0000 | 2.5000 | -37.50% |
| 1995 | 6.2820 | 6.5000 | 8.2500 | 3.7500 | 4.0000 | -36.00% |
| 1994 | 9.1408 | 12.5000 | 12.5000 | 6.0000 | 6.2500 | -47.92% |
| 1993 | 10.1815 | 9.2500 | 13.5000 | 8.2500 | 12.0000 | 41.18% |
| 1992 | 6.1822 | 5.7520 | 9.5000 | 4.5000 | 8.5000 | 61.84% |
| 1991 | 4.4890 | 1.7520 | 7.5000 | 1.2520 | 5.2520 | 199.77% |
| 1990 | 1.4064 | 7.0000 | 7.0000 | 0.3760 | 1.7520 | -74.97% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $0.000B |
| Laxai Pharma Ltd., formerly known as NexGen Biofuels Ltd., is a clinical research company. The Company, through its wholly owned subsidiary OSR Holding Corp., provides integrated services across the drug development spectrum in the United States. Its services include biostatistics, data management (EDC, Hybrid and Paper), CDISC consulting, medical writing, monitoring, regulatory, drug safety, and training. Laxai Pharma Ltd. is based in Tampa, Florida. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $132.070B | 24.77 |
| Elevance Health (ELV) | United States | $84.109B | 10.85 |
| CVS Health (CVS) | United States | $76.951B | 9.56 |
| Cencora (COR) | United States | $56.664B | 19.71 |
| DiDi Global (DIDIY) | China | $22.591B | 34.29 |
| Natera (NTRA) | United States | $20.935B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.529B | 0.00 |
| Solventum (SOLV) | United States | $12.251B | 12.97 |
| CochLear (CHEOY) | Australia | $11.298B | 0.00 |
| Revvity (RVTY) | United States | $10.529B | 18.12 |
| ICON (ICLR) | Ireland | $10.336B | 9.61 |
| Viatris (VTRS) | United States | $9.730B | 3.34 |
| Doximity (DOCS) | United States | $9.525B | 44.37 |
| Avantor (AVTR) | United States | $8.647B | 12.56 |
| HealthEquity (HQY) | United States | $8.564B | 42.13 |
| Medpace Holdings (MEDP) | United States | $8.476B | 22.51 |
| Sonic Healthcare (SKHHY) | Australia | $8.176B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.716B | 13.16 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.048B | 37.47 |
| Bausch + Lomb (BLCO) | Canada | $3.990B | 23.52 |
| Sotera Health (SHC) | United States | $3.452B | 19.61 |
| Surgery Partners (SGRY) | United States | $2.922B | 38.00 |
| Alignment Healthcare (ALHC) | United States | $2.865B | 0.00 |
| Concentras Parent (CON) | United States | $2.710B | 15.66 |
| Organon (OGN) | United States | $2.259B | 2.40 |
| Ardent Health Partners (ARDT) | United States | $2.091B | 8.91 |
| GeneDx Holdings (WGS) | United States | $2.043B | 78.68 |
| Premier (PINC) | United States | $1.899B | 14.41 |
| Progyny (PGNY) | United States | $1.759B | 38.72 |
| PACS (PACS) | United States | $1.497B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.336B | 26.71 |
| Teladoc Health (TDOC) | United States | $1.195B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.165B | 8.86 |
| Establishment Labs Holdings (ESTA) | $1.059B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.944B | 14.74 |
| Agilon Health (AGL) | United States | $0.919B | 0.00 |
| Nutex Health (NUTX) | United States | $0.890B | 13.45 |
| AMN Healthcare Services Inc (AMN) | United States | $0.795B | 7.44 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.626B | 4.22 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| LifeMD (LFMD) | United States | $0.524B | 0.00 |
| Enhabit (EHAB) | United States | $0.518B | 42.58 |
| Auna S.A (AUNA) | Luxembourg | $0.492B | 11.08 |
| SBC Medicals (SBC) | United States | $0.471B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.462B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.408B | 0.00 |
| Oncology Institute (TOI) | United States | $0.269B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.215B | 0.00 |
| Beauty Health (SKIN) | United States | $0.203B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.137B | 22.33 |
| OncoCyte (OCX) | United States | $0.096B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.066B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Biodesix (BDSX) | United States | $0.050B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.025B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |